|
1.
|
Number 509
ABSTRACT: Vulvar intraepithelial neoplasia (VIN) is an increasingly common problem, particularly among women in their 40s. The term VIN is used to denote high-grade squamous lesions and is subdivided...
|
November 2011
PDF Download
|
|
2.
|
Number 477
(Replaces No. 280, December 2002)
ABSTRACT: Epithelial ovarian cancer is most commonly detected in an advanced stage, when the overall 5-year survival rate is 20–30%. Detection of early-stage ovarian cancer results in improved surviv...
|
March 2011
PDF Download
|
|
3.
|
Number 467
(Replaces No. 344, September 2006)
ABSTRACT: The U.S. Food and Drug Administration has approved both a bivalent and quadrivalent human papillomavirus (HPV) vaccine. The Advisory Committee on Immunization Practices has recommended that...
|
September 2010
PDF Download
|
|
4.
|
Number 463
ABSTRACT: Based on several recent studies, new guidelines for initiation of cervical cancer screening have been developed. Evidence shows that screening before the age of 21 years does not change the...
|
August 2010
PDF Download
|
|
5.
|
Number 412
(Reaffirmed 2012)
ABSTRACT: Aromatase inhibitors appear to be effective as an adjuvant treatment for early-stage and late-stage breast cancer. Their role in chemoprevention of breast cancer in high-risk patients remai...
|
August 2008
PDF Download
|
|
6.
|
Number 396
(Reaffirmed 2010 )
ABSTRACT: Postoperative intravenous (IV) chemotherapy for advanced stage ovarian cancer has been the standard treatment. Recent studies have found significant survival advantages with the use of adju...
|
January 2008
PDF Download
|
|
7.
|
Number 336
(Reaffirmed 2008, Replaces No. 232, April 2000)
ABSTRACT: Tamoxifen may be associated with endometrial proliferation, hyperplasia, polyp formation, invasive carcinoma, and uterine sarcoma. Any symptoms of endometrial hyperplasia or cancer reported...
|
June 2006
PDF Download
|